WednesdayFeb 24, 2021 10:15 am

QualityStocksNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Announces Receipt of Regulatory Approval Powdery Mildew Bio-Fungicide in Canada

MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, has received regulatory approval from Canada’s Pest Management Regulatory Agency (“PMRA”) for use of a powdery mildew bio-fungicide product; the approval covers use of the powdery mildew bio-fungicide suppression treatment on cannabis and hemp products. MustGrow announced more than a year ago that it had completed a definitive licensing agreement to obtain the exclusive treatment from a leading multinational biological and microbial company. The bio-fungicide product, which is not mustard derived, like MustGrow’s other products, is designed to…

Continue Reading

WednesdayFeb 24, 2021 10:11 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces First Order for Rapid COVID-19 Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has placed an initial order for rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system. The test systems, known as COVID-ID Labs, were ordered from XPhyto’s exclusive diagnostic development partner, 3a-diagnostics GmbH ("3a"). The first order consists of 9,600 individual tests; the tests are packaged in 200 kits of 48 tests each. The tests, which should arrive by mid-March 2021, will be used as samples for review and evaluation and will be primarily given to prospective distribution partners and licensees…

Continue Reading

WednesdayFeb 24, 2021 10:01 am

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Live Sees 100% Growth in Live Stream Events, Artist Performances

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, has released an update on its Fan Pass platform. The platform is seeing validating signs in several key categories of growth metrics, including 100% growth in live-stream events and artist performances. FDBL noted that as the month ends, it anticipates that activity will continue to increase, resulting in numbers higher than seen in January 2021. “Metrics mean everything, no matter whether they’ve increased or decreased, and they continue to guide our team on the journey toward success on…

Continue Reading

WednesdayFeb 24, 2021 9:43 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Appoints New Chairman of the Board

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced the appointment of James Sapirstein, president and CEO, as chairman of the company’s board of directors, effective immediately. Sapirstein succeeds Edward J. Borkowski, who joined the AzurRx board in May 2015 and has served as chairman since April 2016. Borkowski will remain as lead independent director of the board of directors. “Having served on AzurRx’s board since 2015, I am committed to ensuring a prosperous future for the company,” said Borkowski. “Under James’ leadership, AzurRx has strategically expanded…

Continue Reading

WednesdayFeb 24, 2021 9:32 am

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Closes $17.6M Private Placement; Reaches Key Milestones in Developing AI-Driven Model of Ovarian Cancer

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery closed on its previously announced private placement of common stock and warrants. Priced at-the-market under Nasdaq rules, the 9,043,766 shares of common stocks and warrants were issued and sold by the company in order to purchase no more than 4,521,883 shares of common stock in the private placement. The common stock and associated warrants were issued for $1.95 each, with the warrants having an exercise price of $2 per share. The shares are exercisable immediately; however, they do have a five and…

Continue Reading

TuesdayFeb 23, 2021 3:32 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc.’s App Addresses Treatment Barriers

United Medical Equipment (“UME,” “UMEBSNI”) is focused on providing reliable resources and solutions to help health-care systems work smarter, providers work more proficiently, and patients live healthier lives. Essential to any treatment plan are medication management and collaboration between patient and physician. Two large barriers in medication adherence include poor provider-patient communication and inadequate knowledge about a drug (https://ibn.fm/qzXy6). United Medical has developed a medication management solution to address these barriers: a free app available for download on the Apple App Store and Google Play. A recent article discussing the solution reads, “The free seven-day trial version of the Medication…

Continue Reading

TuesdayFeb 23, 2021 3:09 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Funneling Combined Talent, Expertise into Key Projects

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF), a Canadian junior exploration company, has, in 2020, acquired low-risk, high-quality land in its search for new deposits of gold. New projects and exploration phases are in the works as the company moves into 2021. The company’s goal is to funnel its team’s combined talent and expertise into select projects that provide stability and de-risk the investment. A recent article discussing this reads, “As a junior gold mining company, GoldHaven has its eye on the price of gold and the jurisdictions’ stability with every project undertaken. The ability to read the market and navigate…

Continue Reading

TuesdayFeb 23, 2021 2:56 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Sequire Harnesses the Power of Big Data for Reliable Analytics

SRAX (NASDAQ: SRAX) is focused on unlocking data and insights through its software-as-a-service (“Saas”) platform, Sequire. The platform helps its users unlock the power of data so they can activate marketing campaigns that engage both current and prospective investors. A recent article discussing this reads, “Sequire is the answer for many public companies looking to harness the power of big data for reliable analytics derived from the platform’s 3 million+ active users, a group which includes investors and traders from over 90 public companies (https://ibn.fm/tuibH). The platform’s unique tools help users obtain insights through investor intelligence and outreach, warrant tracking,…

Continue Reading

TuesdayFeb 23, 2021 12:27 pm

QualityStocksNewsBreaks – RIV Capital Inc. (formerly Canopy Rivers Inc.) (TSX: RIV) (OTC: CNPOF) Closes Plan of Arrangement to Pave Way for U.S. Market Entry

RIV Capital (formerly Canopy Rivers) (TSX: RIV) (OTC: CNPOF) has completed the previously announced plan of arrangement involving Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC). Under the arrangement, RIV Capital, through its wholly-owned subsidiary, RIV Capital Corporation (formerly Canopy Rivers Corporation), transferred its interests in TerrAscend Corp., TerrAscend Canada Inc., Les Serres Vert Cannabis Inc. ("Vert Mirabel") (other than the shares transferred to Serres Bertrand), and The Tweed Tree Lot Inc. (collectively, the "transferred assets") to Canopy Growth. The assets were transferred in exchange for approximately $115 million in cash, 3,647,902 common shares of Canopy Growth (having a value of…

Continue Reading

TuesdayFeb 23, 2021 11:38 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Submits Sales License Application to Health Canada

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, announced that, through its wholly owned subsidiary Pure Extracts Manufacturing Corp., it has submitted an application to Health Canada to amend its current license to permit the sale of cannabis extract products. Pure Extracts plans to sell such extracts to provincially authorized distributors and retailers nationwide. This announcement comes on the heels of the company entering a distribution agreement with a large Canadian Licensed Producer to distribute Pure Extracts’ vape and edible products. The company…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered